Cheng Y, Wu L, Huang D, Wang Q, et al. Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES). Lung Cancer 2023;188:107455.
PMID: 38224653